Impact of Broad-Spectrum Antibiotic Exposure on CAR-T Therapy Outcomes in B-Cell Lymphoma: A Multicenter International Study
Roni Shouval(Memorial Sloan Kettering Cancer Center), Marco Ruella(Parker Institute for Cancer Immunotherapy), Natalie Smith(City Of Hope National Medical Center), Jakub Svoboda(UPMC Hillman Cancer Center), Sophia Stock(German Cancer Research Center), Tsila Zuckerman(Johannes Gutenberg University Mainz), Elise A. Chong(Hospital of the University of Pennsylvania), Stefan K. Barta(University of Pennsylvania), Avichai Shimoni, Ronit Marcus(Sheba Medical Center), Gunjan L. Shah(Cornell University), Richard J. Lin(Cornell University), Giulia Gabrielli(Hospital of the University of Pennsylvania), Magdalena Corona(Memorial Sloan Kettering Cancer Center), Ying Taur(Memorial Sloan Kettering Cancer Center), Jonathan U. Peled(Memorial Sloan Kettering Cancer Center), Ofrat Beyar‐Katz(Rambam Health Care Campus), Guido Ghilardi(Hospital of the University of Pennsylvania), Daniel J. Landsburg(University of Pennsylvania), Parastoo B. Dahi(Memorial Sloan Kettering Cancer Center), Michael Scordo(Cornell University), Arnon Nagler(Sheba Medical Center), Kai Rejeski(Memorial Sloan Kettering Cancer Center), Abraham Avigdor(Sheba Medical Center), Sandeep Raj(Memorial Sloan Kettering Cancer Center), Alejandro Luna(Memorial Sloan Kettering Cancer Center), Stephen J. Schuster(Hospital of the University of Pennsylvania), Hazim Khatib(Rambam Health Care Campus), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Gilles Salles(Memorial Sloan Kettering Cancer Center), Sunita D. Nasta(University of Pennsylvania), John Slingerland(Cornell University), Lorenzo Falchi(Memorial Sloan Kettering Cancer Center), Teng Fei(Wuhan University), Jae H. Park(Memorial Sloan Kettering Cancer Center), Maria Lia Palomba(Memorial Sloan Kettering Cancer Center), Marion Subklewe(LMU Klinikum), Noa Golan Accav(Sheba Medical Center), Marcel R.M. van den Brink(City Of Hope National Medical Center)
Cited by 1
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k